- Investing Ideas
- Global Biotech Breakthroughs
Global Biotech Breakthroughs
Results
95
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
95 companies
AC Immune
Market Cap: US$249.3m
A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
ACIU
US$2.52
7D
-15.7%
1Y
-3.1%
Oxford Biomedica
Market Cap: UK£957.0m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£7.92
7D
-0.9%
1Y
136.4%
GNI Group
Market Cap: JP¥159.3b
Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.
2160
JP¥2,861.00
7D
16.3%
1Y
-25.0%
Kuros Biosciences
Market Cap: CHF 1.0b
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 26.04
7D
3.2%
1Y
13.0%
Altimmune
Market Cap: US$548.5m
A clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases.
ALT
US$4.38
7D
-3.3%
1Y
-28.3%
NewAmsterdam Pharma
Market Cap: US$4.1b
A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease.
NAMS
US$35.58
7D
2.7%
1Y
103.0%
Ocugen
Market Cap: US$524.6m
A biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients’ health.
OCGN
US$1.60
7D
13.5%
1Y
154.0%
Noile-Immune Biotech
Market Cap: JP¥6.8b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥156.00
7D
1.3%
1Y
-12.4%
Vera Therapeutics
Market Cap: US$3.0b
A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.
VERA
US$41.76
7D
-1.1%
1Y
53.6%
Oryzon Genomics
Market Cap: €247.6m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system) disorders.
ORY
€3.14
7D
-0.3%
1Y
5.9%
Praxis Precision Medicines
Market Cap: US$9.3b
A clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States.
PRAX
US$335.28
7D
5.7%
1Y
350.1%
Healios K.K
Market Cap: JP¥48.3b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥358.00
7D
-6.3%
1Y
8.5%
Unicycive Therapeutics
Market Cap: US$135.0m
A clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States.
UNCY
US$6.28
7D
1.3%
1Y
1.8%
Anavex Life Sciences
Market Cap: US$381.8m
Operates as a biopharmaceutical company.
AVXL
US$4.12
7D
4.8%
1Y
-50.1%
Active Biotech
Market Cap: SEK 123.9m
A biotechnology company, engages in the research, development, and production of pharmaceutical products in Sweden.
ACTI
SEK 0.047
7D
19.3%
1Y
-48.4%
Aimed Bio
Market Cap: ₩3.3t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩51,700.00
7D
-0.2%
1Y
n/a
Rhythm Pharmaceuticals
Market Cap: US$6.7b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$99.78
7D
1.7%
1Y
82.5%
Diamyd Medical
Market Cap: SEK 2.3b
Develops precision medicine therapies for the treatment of autoimmune diabetes.
DMYD B
SEK 16.40
7D
-3.8%
1Y
7.8%
Everest Medicines
Market Cap: HK$14.0b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$40.76
7D
3.8%
1Y
-9.0%
Japan Tissue Engineering
Market Cap: JP¥25.6b
Engages in the regenerative medicine business in Japan.
7774
JP¥631.00
7D
5.0%
1Y
28.8%
Captor Therapeutics Spolka Akcyjna
Market Cap: zł455.6m
A biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
CTX
zł82.40
7D
0.7%
1Y
67.5%
Mirum Pharmaceuticals
Market Cap: US$6.3b
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.
MIRM
US$105.16
7D
2.0%
1Y
100.5%
Ionis Pharmaceuticals
Market Cap: US$13.5b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$83.15
7D
3.2%
1Y
157.3%
Amicus Therapeutics
Market Cap: US$4.5b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$14.34
7D
0.2%
1Y
56.0%
Creative Medical Technology Holdings
Market Cap: US$6.6m
A commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States.
CELZ
US$1.90
7D
2.2%
1Y
-64.8%
Day One Biopharmaceuticals
Market Cap: US$1.2b
A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.
DAWN
US$11.78
7D
3.8%
1Y
-3.3%
Savara
Market Cap: US$1.4b
A clinical stage biopharmaceutical company, focuses on rare respiratory diseases.
SVRA
US$5.53
7D
-1.3%
1Y
108.7%
Prelude Therapeutics
Market Cap: US$229.1m
A clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients.
PRLD
US$2.78
7D
24.7%
1Y
233.8%
Benitec Biopharma
Market Cap: US$364.5m
A clinical-stage biotechnology company, focuses on the development of novel genetic medicines.
BNTC
US$10.64
7D
2.5%
1Y
1.0%
Fortress Biotech
Market Cap: US$104.3m
A biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products.
FBIO
US$3.36
7D
-6.9%
1Y
114.0%
CStone Pharmaceuticals
Market Cap: HK$9.1b
A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.
2616
HK$6.05
7D
2.4%
1Y
95.2%
InnoCare Pharma
Market Cap: HK$25.3b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$12.72
7D
2.3%
1Y
63.9%
3billion
Market Cap: ₩434.5b
Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.
A394800
₩14,710.00
7D
6.3%
1Y
145.2%
CanSino Biologics
Market Cap: HK$12.7b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$33.98
7D
1.9%
1Y
-0.9%
Sierra Oncology
Market Cap: US$1.3b
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.
SRRA
US$54.99
7D
0.06%
1Y
179.4%
Poltreg
Market Cap: zł123.1m
A biotechnology company, researches and develops therapies for autoimmune diseases.
PTG
zł26.40
7D
-3.3%
1Y
-30.5%